Cardiol Therapeutics Meets MAVERIC Enrollment Goal and Expands Trial for CardiolRx™ Efficacy Study #Canada #Toronto #Cardiol_Therapeutics #MAVERIC_trial #CardiolRx™

Cardiol Therapeutics Meets MAVERIC Enrollment Goal and Expands Trial for CardiolRx™ Efficacy Study #Canada #Toronto #Cardiol_Therapeutics #MAVERIC_trial #CardiolRx™
Cardiol Therapeutics Obtains Over $7 Million from Warrant Exercise to Support Innovative Heart Treatment Trials #Canada #Toronto #Cardiol_Therapeutics #CardiolRx #MAVERIC_trial
Cardiol Therapeutics Unveils $150 Million Base Shelf Prospectus for Future Securities Offerings #Canada #Toronto #Heart_Disease #Cardiol_Therapeutics #CardiolRx
Cardiol Therapeutics to Showcase Innovations at H.C. Wainwright Investment Conference 2026 #Canada #Toronto #Cardiol_Therapeutics #CardiolRx #MAVERIC_Program